• Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Hanall Biopharma Co Ltd

+ Add to Watchlist

009420:KS

4,235 KRW 195 4.83%

As of 02:10:00 ET on 10/23/2014.

Snapshot for Hanall Biopharma Co Ltd (009420)

Open: 4,055 Day's Range: 4,040 - 4,285 Volume: 270,318
Previous Close: 4,040 52wk Range: 3,555 - 6,350 1-Yr Rtn: -31.80%

Stock Chart for 009420

No chart data available.
  • 009420:KS 4,235
  • 1D
  • 1M
  • 1Y
4,040
Interactive 009420 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 009420

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) -525.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 177,038.83
Shares Outstanding (M) 41.80
30 Day Average Volume 202,634
Price/Book (mrq) 2.8681
Price/Sale (ttm) 2.3192
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 12/29/2009
5 Year Dividend Growth -
Next Earnings Announcement 11/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 009420

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 009420

HANALL BIOPHARMA CO., LTD. manufactures prescription drugs for hospitals. The Company specializes in making oral and non-oral antibiotics and amino-acid infusions.

Kim Sung-WookPresident/CEO/Co-Rep DirectorPark Seung-GukCo-Rep Director
Jo Nam-YongSenior Managing DirectorLee Han-SuManaging Director
More Company Profile & Key Executives for 009420

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil